185 related articles for article (PubMed ID: 35802185)
1. [Continue or interrupt? Antirheumatic treatment in elective surgery].
Albrecht K; Leipe J
Z Rheumatol; 2022 Aug; 81(6):492-500. PubMed ID: 35802185
[TBL] [Abstract][Full Text] [Related]
2. [Perioperative management of treatment of patients with inflammatory rheumatic diseases : Updated recommendations of the German Society of Rheumatology].
Albrecht K; Poddubnyy D; Leipe J; Sewerin P; Iking-Konert C; Scholz R; Krüger K
Z Rheumatol; 2022 Apr; 81(3):212-224. PubMed ID: 34928422
[TBL] [Abstract][Full Text] [Related]
3. Perioperative management of patients with inflammatory rheumatic diseases : Updated recommendations of the German Society for Rheumatology.
Albrecht K; Poddubnyy D; Leipe J; Sewerin P; Iking-Konert C; Scholz R; Krüger K
Z Rheumatol; 2023 Jan; 82(Suppl 1):1-11. PubMed ID: 35235025
[TBL] [Abstract][Full Text] [Related]
4. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Fraenkel L; Bathon JM; England BR; St Clair EW; Arayssi T; Carandang K; Deane KD; Genovese M; Huston KK; Kerr G; Kremer J; Nakamura MC; Russell LA; Singh JA; Smith BJ; Sparks JA; Venkatachalam S; Weinblatt ME; Al-Gibbawi M; Baker JF; Barbour KE; Barton JL; Cappelli L; Chamseddine F; George M; Johnson SR; Kahale L; Karam BS; Khamis AM; Navarro-Millán I; Mirza R; Schwab P; Singh N; Turgunbaev M; Turner AS; Yaacoub S; Akl EA
Arthritis Rheumatol; 2021 Jul; 73(7):1108-1123. PubMed ID: 34101376
[TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg JE; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
Ann Rheum Dis; 2020 Jun; 79(6):685-699. PubMed ID: 31969328
[TBL] [Abstract][Full Text] [Related]
6. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D
Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816
[TBL] [Abstract][Full Text] [Related]
7. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gililland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
Arthritis Rheumatol; 2022 Sep; 74(9):1464-1473. PubMed ID: 35722708
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology.
Barth K; Gill H; Singh N
Curr Opin Rheumatol; 2024 Mar; 36(2):113-119. PubMed ID: 38126228
[TBL] [Abstract][Full Text] [Related]
9. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
10. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
J Arthroplasty; 2022 Sep; 37(9):1676-1683. PubMed ID: 35732511
[TBL] [Abstract][Full Text] [Related]
11. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
Michaud K; Pedro S; Wipfler K; Agarwal E; Katz P
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086
[TBL] [Abstract][Full Text] [Related]
12. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1399-1408. PubMed ID: 35718887
[TBL] [Abstract][Full Text] [Related]
13. HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
Gremese E; Gasbarrini A; Ferraccioli G
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32098858
[No Abstract] [Full Text] [Related]
14. Rheumatoid arthritis.
Di Matteo A; Bathon JM; Emery P
Lancet; 2023 Nov; 402(10416):2019-2033. PubMed ID: 38240831
[TBL] [Abstract][Full Text] [Related]
15. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
[TBL] [Abstract][Full Text] [Related]
16. Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis.
Riley TR; George MD
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33597206
[TBL] [Abstract][Full Text] [Related]
17. 'Should we stop or continue conventional synthetic (including glucocorticoids) and targeted DMARDs before surgery in patients with inflammatory rheumatic diseases?'.
Goodman S M; George M D
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32719151
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Janus kinase inhibitors in the treatment of rheumatoid arthritis: a systemic literature review.
Jegatheeswaran J; Turk M; Pope JE
Immunotherapy; 2019 Jun; 11(8):737-754. PubMed ID: 30955397
[TBL] [Abstract][Full Text] [Related]
19. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
[TBL] [Abstract][Full Text] [Related]
20. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register.
Redeker I; Albrecht K; Kekow J; Burmester GR; Braun J; Schäfer M; Zink A; Strangfeld A
Ann Rheum Dis; 2022 Jan; 81(1):41-47. PubMed ID: 34321218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
